David E. Clements

4.5k citations

28 papers · 3.6k indexed · 2 hit papers · h-index 20

Impact in

Infectious Diseases top 0.5%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
Public Health, Environmental and Occupational Health top 0.2%
- Mosquito-borne diseases and control
- Malaria Research and Control

Papers in ⓘ

Public Health, Environmental and Occupational Health 20
- Mosquito-borne diseases and control 20
- Malaria Research and Control 5
Infectious Diseases 18
- Viral Infections and Vectors 17
- Viral Infections and Outbreaks Research 6

Co-authors: Steven Ogata (9 shared papers)Stephen C. Harrison (3 shared papers)Yorgo Modis (3 shared papers)Beth-Ann Coller (6 shared papers)James H. Strauss (1 shared paper)Michael G. Rossmann (1 shared paper)Richard Kühn (1 shared paper)Timothy S. Baker (1 shared paper)
Journals: Vaccine (9 papers)PLoS ONE (2 papers)Molecular Microbiology (1 paper)Journal of Bacteriology (1 paper)Current Opinion in Immunology (1 paper)
Partner nations: United States Netherlands Italy

In The Last Decade

David E. Clements

27 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Structure of the dengue virus envelope protein after membrane fusion 2004 · 918 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Nature
2003 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by David E. Clements

Since Specialization

Citations

This map shows the geographic impact of David E. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Clements more than expected).

Fields of papers citing papers by David E. Clements

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Clements. The network helps show where David E. Clements may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Clements, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Clements Line = papers co-authored together David E. Clements links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure of the dengue virus envelope protein after membrane fusion Nature ·Yorgo Modis, Steven Ogata, David E. Clements, Stephen C. Harrison Hit paper breakdown →	2004	918
2	A ligand-binding pocket in the dengue virus envelope glycoprotein Proceedings of the National Academy of Sciences ·Yorgo Modis, Steven Ogata, David E. Clements, Stephen C. Harrison Hit paper breakdown →	2003	851
3	Conformational Changes of the Flavivirus E Glycoprotein Structure ·Ying Zhang, Wei Zhang, Steven Ogata, David E. Clements, James H. Strauss, Timothy S. Baker, Richard Kühn, Michael G. Rossmann	2004	358
4	Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein Journal of Virology ·Yorgo Modis, Steven Ogata, David E. Clements, Stephen C. Harrison	2004	349
5	Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys Vaccine ·David E. Clements, Beth-Ann Coller, Michael M. Lieberman, Steven Ogata, Gordon Wang, Kent E. Harada, J. Robert Putnak, John M. Ivy, Michael McDonell, Gary S. Bignami, Iain D. Peters, Julia P. Leung, Carolyn Weeks-Levy, Eileen Nakano, Tom Humphreys	2010	160
6	An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model Vaccine ·J. Robert Putnak, Beth-Ann Coller, Gérald Voss, David W. Vaughn, David E. Clements, Iain D. Peters, Gary S. Bignami, Hou-Shu Houng, Robert C.-M. Chen, David A. Barvir, J Seriwatana, Sylvie Cayphas, Nathalie Garçon, Dirk Gheysen, Niranjan Kanesa-thasan, Mike McDonell, Tom Humphreys, Kenneth H. Eckels, Jean‐Paul Prieels, Bruce L. Innis	2005	130
7	The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease Vaccine ·Beth-Ann Coller, David E. Clements, Andrew J. Bett, Sangeetha L. Sagar, Jan H. ter Meulen	2011	116
8	Dengue vaccines: progress and challenges Current Opinion in Immunology ·Beth-Ann Coller, David E. Clements	2011	101
9	Use of Recombinant Envelope Proteins for Serological Diagnosis of Dengue Virus Infection in an Immunochromatographic Assay Clinical and Diagnostic Laboratory Immunology ·Andrea J. Cuzzubbo, Timothy P. Endy, Ananda Nisalak, Siripen Kalayanarooj, David W. Vaughn, Steven Ogata, David E. Clements, Peter L. Devine	2001	88
10	Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys Clinical and Vaccine Immunology ·Michael M. Lieberman, Vivek R. Nerurkar, Luo Haiyan, Bruce C. Cropp, Ricardo Carrion, Melissa de la Garza, Beth-Ann Coller, David E. Clements, Steven Ogata, Teri Ann S. Wong, Tim Martyak, Carolyn Weeks-Levy	2009	62
11	Preparation and immunogenic properties of a recombinant West Nile subunit vaccine Vaccine ·Michael M. Lieberman, David E. Clements, Steven Ogata, Gordon Wang, Gloria Corpuz, Teri Ann S. Wong, Tim Martyak, Lynne Gilson, Beth-Ann Coller, Julia P. Leung, Douglas M. Watts, Robert B. Tesh, Marina Siirin, Amélia Travassos da Rosa, Tom Humphreys, Carolyn Weeks-Levy	2006	59
12	Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates Vaccine ·Dhanasekaran Govindarajan, Steven Meschino, Liming Guan, David E. Clements, Jan H. ter Meulen, Danilo R. Casimiro, Beth-Ann Coller, Andrew J. Bett	2015	59
13	Safety and Cellular and Humoral Immune Responses of a Booster Dose of Varicella Vaccine 6 Years after Primary Immunization The Journal of Infectious Diseases ·Barbara Watson, Edward Rothstein, Hans‐Gert Bernstein, Allan M. Arbeter, Ann M. Arvin, Stephen A. Chartrand, David E. Clements, Mary L. Kumar, Keith S. Reisinger, Mark M. Blatter, Stuart E. Starr, BRENDA O. STAEHLE, A. Ngai, C. J. White	1995	52
14	Preclinical and clinical development of a dengue recombinant subunit vaccine Vaccine ·Susan B. Manoff, Sarah L. George, Andrew J. Bett, Michele L. Yelmene, Dhanasekaran Govindarajan, Linda M. Eggemeyer, Michele Sausser, Sheri Dubey, Danilo R. Casimiro, David E. Clements, Timothy Martyak, Vidya Pai, D E Parks, Beth-Ann Coller	2015	51
15	Multiple copies of a DNA sequence from Pseudomonas syringae pathovar phaseolicola abolish thermoregulation of phaseolotoxin production Molecular Microbiology ·Karla B. Rowley, David E. Clements, Morton Mandel, Tom Humphreys, Suresh S. Patil	1993	40
16	Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis Vaccine ·Douglas M. Watts, Robert B. Tesh, Marina Siirin, Amélia Travassos da Rosa, Patrick C. Newman, David E. Clements, Steven Ogata, Beth-Ann Coller, Carolyn Weeks-Levy, Michael M. Lieberman	2006	35
17	A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates Frontiers in Immunology ·Liana Medina, Albert To, Michael M. Lieberman, Teri Ann S. Wong, Madhuri Namekar, Eileen Nakano, Hanné Andersen, Jake Yalley-Ogunro, Jack Greenhouse, Stephen Higgs, Yan-Jang S. Huang, Dana L. Vanlandingham, Jaime S Horton, David E. Clements, Axel T. Lehrer	2018	33
18	Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice Vaccine ·Axel T. Lehrer, Teri-Ann S. Wong, Michael M. Lieberman, Tom Humphreys, David E. Clements, Russell R. Bakken, Mary Kate Hart, William D. Pratt, John M. Dye	2017	28
19	A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations PLoS ONE ·Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, Angela M. Bosco‐Lauth, Christopher B. Fox, Richard A. Bowen, David E. Clements, Timothy Martyak, D E Parks, Susan L. Baldwin, Steven G. Reed, Rhea N. Coler	2016	26
20	Sentence boundary detection: a comparison of paradigms for improving MT quality Daniel J. Walker, David E. Clements, Maki Darwin, Jan W. Amtrup	2001	25

About David E. Clements

David E. Clements is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Molecular Biology and Insect Science, having authored 28 papers that have together received 3.6k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (20 papers), Viral Infections and Vectors (17 papers), Viral Infections and Outbreaks Research (6 papers), Malaria Research and Control (5 papers), Insect symbiosis and bacterial influences (3 papers), Invertebrate Immune Response Mechanisms (2 papers), Plant-Microbe Interactions and Immunity (2 papers) and Legume Nitrogen Fixing Symbiosis (2 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Public Health, Environmental and Occupational Health (3.0k citations), Virology (370 citations), Insect Science (507 citations) and Endocrinology (162 citations). David E. Clements has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Steven Ogata, Stephen C. Harrison, Yorgo Modis, Beth-Ann Coller, James H. Strauss, Michael G. Rossmann, Richard Kühn, Timothy S. Baker, Ying Zhang and Wei Zhang. Their work appears in journals such as Vaccine, PLoS ONE, Molecular Microbiology, Journal of Bacteriology and Current Opinion in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact